NCT02024269View on ClinicalTrials.gov

Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

June 30, 2017

Conditions
Dry Macular Degeneration
Interventions
BIOLOGICAL

Adipose Derived Stem Cells

Trial Locations (1)

Unknown

Bioheart, Sunrise

Sponsors

Lead Sponsor

Bioheart, Inc.
All Listed Sponsors
lead

Bioheart, Inc.

INDUSTRY

NCT02024269 - Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration | Biotech Hunter | Biotech Hunter